Harfst & Associates’s West Pharmaceutical WST Stock Holding History

Harfst & Associates’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,732	Closed	-$836K	–	121
2025 Q1	$836K	Sell	3,732 -3,908	-51%	-$875K	0.19%	62
2024 Q4	$2.5M	Buy	7,640 +156	+2%	+$51.1K	0.52%	37
2024 Q3	$2.25M	Buy	7,484 +551	+8%	+$165K	0.5%	40
2024 Q2	$2.28M	Buy	6,933 +106	+2%	+$34.9K	0.53%	34
2024 Q1	$2.7M	Sell	6,827 -153	-2%	-$60.5K	0.64%	24
2023 Q4	$2.46M	Sell	6,980 -165	-2%	-$58.1K	0.65%	28
2023 Q3	$2.68M	Sell	7,145 -12	-0.2%	-$4.5K	0.75%	19
2023 Q2	$2.74M	Buy	7,157 +65	+0.9%	+$24.9K	0.73%	20
2023 Q1	$2.46M	Sell	7,092 -7	-0.1%	-$2.43K	0.7%	20
2022 Q4	$1.67M	Buy	7,099 +260	+4%	+$61.2K	0.48%	41
2022 Q3	$1.68M	Buy	6,839 +577	+9%	+$142K	0.51%	37
2022 Q2	$1.89M	Sell	6,262 -255	-4%	-$77.1K	0.54%	25
2022 Q1	$2.68M	Buy	6,517 +539	+9%	+$221K	0.62%	18
2021 Q4	$2.8M	Buy	5,978 +302	+5%	+$142K	0.71%	14
2021 Q3	$2.41M	Sell	5,676 -299	-5%	-$127K	0.67%	16
2021 Q2	$2.15M	Sell	5,975 -361	-6%	-$130K	0.62%	20
2021 Q1	$1.79M	Buy	6,336 +1,095	+21%	+$308K	0.54%	31
2020 Q4	$1.48M	Buy	5,241 +376	+8%	+$106K	0.55%	23
2020 Q3	$1.34M	Sell	4,865 -1,128	-19%	-$310K	0.57%	19
2020 Q2	$1.36M	Sell	5,993 -346	-5%	-$78.6K	0.59%	16
2020 Q1	$965K	Buy	6,339 +211	+3%	+$32.1K	0.49%	23
2019 Q4	$921K	Buy	6,128 +93	+2%	+$14K	0.35%	37
2019 Q3	$855K	Buy	6,035 +48	+0.8%	+$6.8K	0.35%	32
2019 Q2	$749K	Buy	5,987 +341	+6%	+$42.7K	0.31%	37
2019 Q1	$622K	Buy	5,646 +882	+19%	+$97.2K	0.27%	44
2018 Q4	$467K	Buy	4,764 +403	+9%	+$39.5K	0.22%	51
2018 Q3	$538K	Buy	4,361 +154	+4%	+$19K	0.23%	40
2018 Q2	$417K	Buy	4,207 +75	+2%	+$7.43K	0.18%	49
2018 Q1	$364K	Buy	4,132 +193	+5%	+$17K	0.15%	62
2017 Q4	$388K	Buy	3,939 +132	+3%	+$13K	0.16%	57
2017 Q3	$366K	Hold	3,807	–	–	0.15%	54
2017 Q2	$359K	Buy	3,807 +1,519	+66%	+$143K	0.14%	51
2017 Q1	$186K	Buy	+2,288	New	+$186K	0.08%	80